Glycoprotein D (gD) of herpes simplex virus contains three utilized sites (Asn-X-Ser/Thr) for addition of asparagine-linked carbohydrates (N-CHO). Previously, we used oligonucleotide-directed mutagenesis to alter serine or threonine residues to alanine at each N-CHO addition site. Studies with monoclonal antibodies showed that a mutant protein lacking all three sites (now designated AAA) was structurally altered because of the amino acid change at residue 96 as well as the absence of the N-CHO. In this study, we constructed additional single mutations at site 1 (residues 94 and 96) and found that in most cases, the amino acid change itself adversely affected the conformation of gD. However, changing asparagine 94 to glutamine (Q) at site 1 had the least effect on gD. We constructed a second triple mutant, QAA, which lacked all three N-CHO signals. The antigenic conformation of QAA was similar to that of gD produced in the presence of tunicamycin (TM-gD). However, binding of MAbs to the AAA protein or to single mutants altered at site 1 was reduced compared with TM-gD. Wild-type gD and QAA proteins were equally susceptible to digestion by trypsin or Staphylococcus aureus V8 protease. In contrast, the AAA protein was more sensitive to trypsin but less sensitive to V8, again suggesting conformational alterations of the AAA protein. Despite what appeared to be large changes in structure, each mutant complemented the infectivity of a virus lacking gD (F-gD,I). We conclude that the N-CHO and amino acids at N-CHO site 1 play an important role in forming and/or maintaining gD structure, but none of the N-CHO are required for gD to function in the complementation assay.
N-CHO themselves or their contribution to protein structure and stability accounted for the loss of infectivity.
In this and other studies (57, 58) , we have investigated the structural and functional importance of the N-CHO present on a single HSV-1 glycoprotein, glycoprotein D-1 (gD-1). gD is present in the virion envelope and contains three utilized N-CHO addition sites (7, 63, 64) and two or three 0-linked oligosaccharides (56) . The protein stimulates high titers of complement-independent neutralizing antibody (5, 10, 39) , protects animals from virus challenge (3, 32, 35, 60) , and is currently being assessed as a possible human subunit vaccine (1, 15, 16) Studies with anti-gD monoclonal antibodies (MAbs) have implicated the glycoprotein in virus adsorption (17) and penetration (18, 22) and in cell-to-cell fusion (39, 45) . Also, gD plays a role in the ability of HSV to be neuroinvasive (24) . A virus lacking the gD gene (F-gDp) was used in experiments to suggest that gD is involved in binding to a cellular receptor, an event which is presumably essential for virus penetration (26, 33) . Experiments employing mutagenesis of the gD gene have begun to distinguish regions of the molecule involved in the functional sites (13, 34, 42) .
Previously, we used oligonucleotide-directed mutagenesis to eliminate the three N-CHO addition signals (Asn-X-Ser/ Thr) on gD-1 by changing the serine or threonine in the third position to alanine (57) . We found that these N-CHO moieties individually or in combination are not essential for the proper processing or surface expression of gD-1 in transfected cells. In addition, we determined that the substitution of alanine for threonine at site 1 (Ala-1) affected protein structure for two reasons: the absence of N-CHO and the amino acid change itself. Because of this complication, we have now constructed several other mutants with different changes at site 1. We found that changing Asn-94 to glutamine (Q) at site 1 was the least disruptive change to gD-1 structure. We then prepared a triple mutant (QAA) which incorporated this change at site 1 as well as alanine for serine at site 2 (residue 123) and alanine for threonine at site 3 (residue 264). We compared the properties of the two triple mutants, AAA (alanine for threonine or serine at all three N-CHO sites) from the previous study (57) and QAA from this study, to assess the effect of these mutations on the structure and biological activity of the gD-1 protein.
(This work was conducted by Donald L. Sodora in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Program in Microbiology and Virology at the University of Pennsylvania, Philadelphia, 1991.)
MATERIALS AND METHODS
Cell culture and viral strains. COS-1 cells were propagated as described previously (57) . Vero cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum (FBS). VD60 cells were propagated in DMEM containing 5% FBS and 1 mM histidinol (33) . F-gDp virus was grown and titered in VD60 cells without histidinol (33) .
Construction of glycosylation mutants of gD. Oligonucleotide-directed mutagenesis of the gD-1 gene (Patton strain) cloned into M13mpi8 (57) was done by the method of Zoller and Smith (67) as modified by Kunkel et al. (31) . Three synthetic oligonucleotide primers were used to change the Asn-X-Ser/Thr N-CHO signal at site 1. We changed asparagine 94 to glutamine (Gln-1), asparagine 94 to Arg (Arg-1), and threonine 96 to histidine (His-1). These were compared with a previously constructed mutant, Ala-1, formerly called N-CHO 1-, in which threonine 96 was changed to alanine. In addition, we constructed a triple mutant by incorporating the Gln-1 change mentioned above with the serine 123-to-alanine (Ala-2) and threonine 264-to-alanine (Ala-3) changes previously described as N-CHO 2-and N-CHO 3- (57) . This triple mutant is designated QAA. Previously we had constructed a triple mutant with serine-or threonine-to-alanine changes at each N-CHO site. This mutant, formerly known as N-CHO 1,2,3-, is now designated AAA. Each mutation was confirmed by dideoxy sequencing (53) . Each mutant gene was inserted into the nonreplicating eucaryotic expression vector pRSV-nt EPA, which contains the Rous sarcoma virus long terminal repeat as a promoter and a simian virus 40 polyadenylation signal (7) .
Transient expression of gD glycosylation mutants. The calcium phosphate coprecipitation procedure (20) was used as described elsewhere (8, 65) . A 10-,ug portion of DNA was used in each 60-mm-diameter plate of COS-1 cells. For experiments utilizing TM, 2 pxg of the drug per ml was added at 15 h posttransfection. Cells were harvested 48 h posttransfection, and cytoplasmic extracts were prepared (6, 57) .
Antibodies and immunoblot assays. Rabbit polyclonal anti-gD serum (65) was used for Western blotting (immunoblotting) (2) . MAbs DL-li (group lb [40] ) and DL-6 (group II [24] ) were isolated in our laboratory (10) . MAb ABD (group III) was kindly provided by C. Desgranges (55) . DL-ii and ABD recognize distinct discontinuous epitopes on the gD protein (10, 41, 52) . DL-6 recognizes a continuous epitope within amino acid residues 272 to 279 of gD (23) . Immunoblot assays were performed as described previously (57 
RESULTS
Studies on mutations which alter N-CHO site 1 of gD. Previously we found that changing threonine 96 to alanine (Ala-i) had a profound effect on gD structure (57) . This alteration was due to both the absence of N-CHO and the amino acid change itself. N-CHO addition sites 2 and 3 were previously altered by changing serine 123 to alanine (Ala-2) and threonine 264 to alanine (Ala-3) (57). These alterations had relatively little effect on the conformation of gD. In the present study, we created additional mutations at N-CHO site 1 to study how different amino acid changes influence conformation of the protein (Fig. 1) . The asparagine 94-toglutamine (Gln-1) change was constructed with the hope that such a conservative amino acid change would have little effect on protein structure other than prevention of N-CHO addition (54) . Other amino acid changes were designed to investigate whether certain amino acid changes could compensate for the altered antigenic structure which was observed for gD produced in the presence of TM (TM-gD). For example, it was observed (36) that the absence of the hydrophilic N-CHO residues from the vesicular stomatitis virus G protein could be partially compensated for by the replacement of a nearby amino acid with a charged residue. To obtain a clue as to which amino acids might compensate for the N-CHO in gD, the amino acid sequence for gD was compared with those of homologs found in related herpesviruses (Fig. 2) . The sequences were aligned to maximize the conservation in position of the first six cysteine residues of gD-1 with corresponding cysteines in the homologs. The first and second N-CHO addition sites of gD are located between the positions of the first four cysteine residues. The gp5O VOL. 65, 1991 #1 #2 #3 (11) which is cotranslationally cleaved to the mature form of 369 amino acids (38) . The transmembrane region (dotted box) is located near the carboxy terminus (38) . The seven cysteine residues (C) are located at amino acids 66, 106, 118, 127, 189, 202, and 333. gD-1 contains three sites (asparagine at residues 94, 121, and 262) for the addition of N-linked carbohydrates, all of which are utilized (6) . These are depicted as branched structures. The Ala-1, Ala-2, Ala-3, and AAA proteins were reported on previously (57) . They were previously designated N-CHO 1-, N-CHO 2-, N-CHO 3, and N-CHO 1,2,3-, respectively.
protein from pseudorabies virus contains no N-CHO addition sites (47) . Instead, at the position of the first gD N-CHO site, gpSO contains arginine rather than asparagine and histidine rather than threonine. At the position of the second N-CHO site of gD, gpSO contains arginine in place of asparagine and valine in place of serine. The gIV protein from bovine herpesvirus shares the first N-CHO addition site with gD, but the second N-CHO site of gD is missing in gIV. At this position, there is an arginine in place of asparagine and a histidine in place of serine (28, 62) . The gD homolog from equine herpesvirus contains an arginine in place of asparagine at N-CHO site 1 of gD and a lysine in place of asparagine at site 2 (14) . Amino acids in the homologs which might correspond in position to the third N-CHO of gD (asparagine 264) were ambiguous because of sequence divergence outside of the six-cysteine region which ends at amino acid 202 of gD. However, for N-CHO sites 1 and 2, the basic amino acids arginine, histidine, and lysine were present in each homolog which lacked one or both of these sites. We
Analysis of the amino acid residues of gD homologs (single-letter code) corresponding to the region encompassing the first four cysteine residues (boldface) of HSV gD. The gD proteins from HSV-1 and HSV-2, the gpSO protein from pseudorabies virus (PRV) (47) , the gIV protein from bovine herpesvirus (BHV) (28, 62) , and the gD homolog from equine herpesvirus 1 (EHV-1) (14) each contain six cysteine residues whose spacing is conserved. The sequences were aligned according to the spacing between cysteines 1 and 4 of gD (as numbered at the top). In some cases, blanks had to be inserted in the sequences of the homologs to maintain the alignment. Each decided to assay the ability of basic residues to substitute for N-CHO at site 1 of gD-i by changing asparagine 94 to arginine (Arg-1) and threonine 96 to histidine (His-1) (Fig. 2) . The effect of each of these mutations on gD expression, structure and biological function was analyzed. A triple mutant (QAA) which consisted of the glutamine-for-asparagine change at site 1, the alanine-for-serine change at site 2 (residue 123), and the alanine-for-threonine change at site 3 (residue 264) was then prepared. The properties of the two triple mutants, QAA from this study and AAA (alanine for threonine or serine at all three N-CHO sites) from a previous study (57) were compared to assess the effect of these mutations on the structure and biological activity of the two gD-1 proteins produced, both of which lack all N-CHO.
The absence of N-CHO from the gD-1 protein was verified by examining the electrophoretic mobilities of the transfected proteins before and after endo F digestion. Cell extracts were electrophoresed, Western blotted, and reacted with polyclonal anti-gD-1 serum (Fig. 3A) . The absence of one N-CHO site had only a slight effect on electrophoretic mobility; however, the absence of all three sites had a significant effect. The triple mutants were also compared with wild-type TM-gD. The TM-gD protein has a wild-type amino acid sequence but no N-CHO. As observed previously (57), the AAA protein migrated further in the gel than TM-gD. The difference in mobility could reflect differences in either the conformation or posttranslational modifications of AAA. In contrast, the mobility of the QAA protein was similar to that of TM-gD. As expected, the AAA, QAA, and TM-gD proteins were each resistant to endo F treatment (Fig. 3B) , verifying that these proteins totally lack N-CHO.
Antigenic analysis. Previously, a panel of MAbs recognizing discontinuous epitopes on gD was used to analyze changes in protein conformation resulting from single and triple glycosylation mutations (57) . The binding of gD to DL-6, which recognizes a continuous epitope (23) , was used to correct for differences in gD concentration in each extract. In the present study, two representative MAbs which recognize discontinuous epitopes were used: DL-ii (group Tb) (40) and ABD (group III) (55) (Fig. 4) reduced when compared with their reactivity with the wild type, indicating that each mutant was conformationally altered. By this criterion, the Gln-1 mutation was least detrimental to gD conformation, the Arg-1 and Ala-i mutations had greater effects, and the His-1 protein appeared to contain neither discontinuous epitope. (ii) As shown previously (57), the Ala-2 and Ala-3 proteins were not affected.
(iii) The AAA protein reacted with DL-ii and ABD at a level below that obtained with TM-gD. (iv) In contrast, the QAA protein reacted at a level similar to that of TM-gD but lower than the level of wild-type gD. We conclude that N-CHO, particularly N-CHO at site 1, do serve a role in the proper folding and structure of the gD-1 protein. In addition, the positively charged amino acids arginine and histidine failed to compensate for the absence of N-CHO at site 1; in fact, these changes were quite detrimental to protein folding. Sensitivity to proteases. One role ascribed to N-CHO is protection of the glycoprotein from proteolytic degradation (46, 50, 66) . We analyzed the ability of the N-CHO to protect gD from degradation by either trypsin (which cleaves on the carboxy side of arginine or lysine) or V8 protease (which cleaves on the carboxy side of glutamic acid). Cytoplasmic extracts prepared from cells transiently transfected with the wild-type, QAA, or AAA form of the gD-1 gene, were incubated with trypsin or V8 protease for various times. Extracts were electrophoresed, Western blotted, and probed with anti-gD serum (Fig. 5) . The QAA and wild-type proteins were equally susceptible to trypsin (both proteins were partly degraded after 90 min) or V8 (both proteins were fully degraded after 45 min). These results suggest that the presence of N-CHO on wild-type gD does not increase the resistance of the protein to proteases. In contrast, the AAA protein was degraded more rapidly by trypsin (this protein was fully degraded after 60 5) , and 90 min (lanes 6). The treated extracts were then electrophoresed under denaturing conditions, transferred to nitrocellulose (3), reacted with anti-gD-1 serum and then with iodinated protein A, and exposed to X-ray film.
trypsin cleavage sites (arginine or lysine) appear to be more exposed to the enzyme, whereas one or more V8 cleavage sites (glutamic acid) are less exposed to the enzyme. We conclude that the asparagine 94-to-glutamine change at site 1 is less detrimental to gD structure than the threonine 96-toalanine change, as determined by protease sensitivity.
Functional analysis of gD N-CHO mutants. We employed a complementation assay (43) to assess the ability of the gD-1 N-CHO mutant proteins to function when incorporated in the virion envelope of a gD-null virus called F-gDP (33) (Fig.   6 ). As a control, Vero cells were transfected with a plasmid lacking the gD gene before being infected with F-gD,B virus. The background titer obtained (2 x 103 PFU) may be due to recombination between the F-gD,B virus genome and the gD gene contained within the VD60 cell line used to propagate the gD-null virus (25) 65, 1991 mutant, and each time we observed a similar increase in titer. We conclude that the absence of any one or all three of the N-CHO addition sites had no effect on the function of gD as measured in this assay. Furthermore, and in contrast to previous observations (34, 40) , changes in antigenic structure were not correlated with the ability of the mutant proteins to complement F-gDP. The virus preparations obtained from the complementation assay will hereafter be referred to as F-gD,(WT) (i.e., wild type), F-gD,(QAA), F-gDP(AAA), F-gDP(Gln-1) and F-gD,B(Ala-1).
Thermal susceptibility of rescued virus. We previously noted that some gD-1 mutants in which individual cysteine residues were replaced by serine were able to complement F-gDP in a temperature-sensitive fashion (34) . The rescued viruses which were obtained from the complementation assay were more susceptible to thermal denaturation than wild-type virus. We asked whether the structural changes that we had detected in some of the mutant gD proteins might increase the thermolability of virions into which the mutant gD was incorporated. To examine this possibility, we incubated viruses obtained from the complementation assay at various temperatures for 1 h and then tested their infectivity (Fig. 7) . Heat treatment had a similar effect on the infectivity of F-gD,(QAA) and F-gDO(WT); in each case, there was a one-log-unit decrease in titer after 1 h of preincubation of the virus preparation at 44°C. In contrast, F-gDP(AAA) was more susceptible to heat inactivation; after 1 h of preincubation at 42 or 44°C, there was a two-log-unit drop in titer (also see below).
We next determined the rate of inactivation of each virus preparation by incubating virus samples at 44°C for various times prior to titration (Fig. 8) . We suspected that the increase in heat susceptibility observed for F-gDP(AAA) might be due to the amino acid alteration at site 1, so in addition to the wild type and the two triple mutants we tested the rates of inactivation of F-gD,(Gln-1) and F-gD,(Ala-1) (Fig. 8) . The titers of F-gDP(WT), F-gD3(Gln-1), and F-gD,B(QAA) were reduced at similar rates; all were decreased by one log unit within 45 min. In contrast, F-gD3(Ala-1) and F-gD,B(AAA) were inactivated more rapidly; there was a one-log-unit decrease in their titers within 15 min. In one experiment, a small amount of infectious F-gDO(AAA) virus was detected after 1 h at 440C (Fig. 7) . In three subsequent experiments, the results of one of which are shown in Fig. 8 , we were unable to detect any infectious virus under these conditions. The finding that F-gDP(QAA) virus is as resistant to heat as F-gD,3(WT) indicates that the N-CHO on gD-1 do not contribute to the heat stability of HSV. However, other amino acid substitutions at N-CHO site 1 of gD markedly affect virus stability. In each case, an increase in thermal instability was associated with a marked alteration of gD conformation.
DISCUSSION
Our laboratory has carried out detailed structural and immunological studies of HSV gD in an effort to characterize the domains involved in its biological and immunological activities (41) . One goal was to determine the contribution of carbohydrates to the structure and function of the glycoprotein. Earlier, we showed that all three potential N-linked glycosylation sites predicted by the amino acid sequence are utilized in both gD-1 and gD-2 (6). In addition, we found that removal of N-CHO from gD-1 leaves the protein more susceptible to denaturation (as measured by loss of antigenic conformation) during electrophoresis in native acrylamide gels containing low levels of SDS and/or the associated Western blotting (43) . These studies suggested that the N-CHO on gD contribute to some extent to the stability of the protein in the presence of agents such as SDS. In the present studies, we found that the QAA gD protein present in cell extracts was indistinguishable from the wild-type protein in its susceptibility to proteases and was no more heat sensitive than the wild-type protein when present in the virion envelope. A significant finding of the present study is that gD-1 lacking one or all three N-CHO is able to function in virus infection, as measured in a complementation assay.
Importance of N-CHO on gD for its structure. Early studies carried out in our laboratory showed that gD synthesized in procaryotes such as Escherichia coli, where N-linked glycosylation does not occur, lacked discontinuous epitopes (52) . This suggested that addition of N-linked oligosaccharides might be important for folding of gD into its native conformation. It should be noted that our results were in contrast to those of another report which showed that MAb 4S, which recognizes a discontinuous epitope, (site lb [40, 41] ) was able to immunoprecipitate the product made in E. coli (64) .
We next examined the antigenic structure of gD synthesized in an in vitro translation system (37, 38) . Discontinuous epitopes were not formed in gD-1 or gD-2 during in vitro translation, even when protein synthesis occurred in the presence of microsomal vesicles which provide the enzymes necessary for addition of N-CHO and removal of the signal peptide. The conclusions were that addition of N-CHO is not sufficient to ensure proper folding and that other factors not present in the in vitro system are involved in gD folding. The antigenic structure of gD in TM-treated HSV-1-and HSV-2-infected cells was also examined (37) . These studies showed that many discontinuous epitopes formed on both gD-1 and gD-2, even when no N-linked oligosaccharides were added to the protein, suggesting that they are not critical for the folding of gD into its native structure in infected eucaryotic cells. However, the studies with MAbs were not carried out in a quantitative manner.
In this and other recent studies (57), we found that mutant forms of gD which lack the signals for addition of all three N-CHO show quantitative changes in binding to many MAbs to discontinuous epitopes. The structural changes were associated with the absence of N-CHO at asparagine 94 and were also attributable to the amino acid alterations of asparagine 94 or threonine 96. Elimination of the N-CHO at sites 2 and 3 had almost no effect on protein structure (57) . For VSV G protein, charged amino acids can compensate for the absence of nearby N-CHO (48) . It was of interest to note that gD homologs contain basic amino acids at positions corresponding to N-CHO sites 1 and 2 of gD. However, changing asparagine 94 to arginine or threonine 96 to histidine resulted in more drastic alterations in gD structure. Thus, for gD, substitution of basic amino acids did not compensate for the absence of the N-CHO at N-CHO site 1.
Complementation studies. The importance of N-CHO for the biological activity of a glycoprotein varies (4, 20) . In the case of HSV glycoproteins, previous experiments employed drugs which altered the addition and/or processing of carbohydrates during HSV synthesis (49, (59) (60) (61) or used enzymes which removed N-CHO directly from HSV-1 virions (30) . The overall conclusion is that N-CHO present on HSV glycoproteins are important for virus infectivity. In light of our results, the N-CHO which are essential for HSV infectivity must be attached to glycoproteins other than gD.
Previously, we postulated that gD function requires its proper native structure. This was based on the finding that a variety of deletion mutations which caused extensive structural changes in gD were unable to complement F-gDP (34, 42) . Moreover, similar mutations could not be recombined into the viral genome to produce viable viruses (13) . In contrast, mutations which had little effect on protein structure were generally able to complement and form viable recombinants. One exceptional group of mutations consisted of those which had little effect on structure but were not able to complement or form viable recombinants (26, 42) . Mutations which fell into the latter category were interpreted to represent those which eliminated a functional region of gD.
Until now, no gD mutants that exhibit large structural changes but are still functional have been identified. Therefore, it was surprising to us that all of the gD N-CHO mutants, even those exhibiting significant structural changes, complemented F-gD,3 (42, 43 (66) and RNase B (50), from proteolytic degradation. Our observation that the QAA protein is unchanged from wild-type gD in sensitivity to trypsin and V8 suggests that N-CHO do not play this protective role for gD, at least as far as these two proteases are concerned. Interestingly, the AAA mutant showed an enhanced sensitivity to trypsin but a decreased sensitivity to V8. This suggests that altered susceptibility to proteases, either enhanced or diminished, can be used as a basis for a probe of the physical structure of mutated proteins in much the same way as MAbs are used.
Altering cysteine 106 or cysteine 127 of gD-1 to serine makes the protein temperature sensitive, and virions containing these proteins are heat labile (34) . In this study, we found that virions containing the Ala-1 or the AAA form of gD were heat labile, but those containing QAA were as stable as the wild type. Thus, it is possible that the AAA mutation, if recombined into the HSV genome, will yield a temperature-sensitive phenotype. Such a possibility might explain our lack of success in isolating such a recombinant at 37°C. Experiments addressing this point are planned for the future.
